ODM Solubility Manufacturers & Suppliers

Precision Botanical CDMO & CRO Solutions: Overcoming Bioavailability Hurdles Through Advanced Solid Dispersions, Nanocrystallization, and Phyto-Solubilization Technologies.

Discovery & Formulation Services

Featured Contract Solubility & R&D Solutions

Targeted pharmaceutical, biopharmaceutical, and nutraceutical contract R&D offerings powered by modern phytochemistry and clinical verification.

China Screening of the active ingredient(s) of plants Manufacturer, Manufacturers
China Screening of the active ingredient(s) of plants Manufacturer, Manufacturers
Explore Capability
OEM Animal study Supplier, Suppliers
OEM Animal study Supplier, Suppliers
Explore Capability
OEM In Vitro Test /Research Service Manufacturers, Suppliers
OEM In Vitro Test /Research Service Manufacturers, Suppliers
Explore Capability
ODM Clinic study (Phase1 - Phase 4) Manufacturer, Suppliers
ODM Clinic study (Phase1 - Phase 4) Manufacturer, Suppliers
Explore Capability
ODM Study and evaluation of the potency of the botanical active ingredient(s)
ODM Study and evaluation of the potency of botanical active ingredient(s)
Explore Capability
China Establishment of analysis methods of active ingredients Supplier, Suppliers
China Establishment of analysis methods of active ingredient(s) Supplier
Explore Capability
Botanical Active Ingredient Screening
Botanical Active Ingredient High-Throughput Screening & Sourcing
Explore Capability
Potency Evaluation of Natural Materials
Natural Raw Material Potency Evaluation by Season & Geographic Origin
Explore Capability
Technical White Paper

Overcoming Bioavailability Bottlenecks: The Solubility Imperative

In modern biopharmaceutics, more than 70% of emerging active pharmaceutical ingredients (APIs) and over 85% of complex botanical isolates fall under BCS Class II (low solubility, high permeability) or BCS Class IV (low solubility, low permeability). Without specialized solubility enhancement, prospective blockbusters suffer from low oral bioavailability, erratic pharmacokinetic profiles, and commercial obsolescence.

Amorphous Solid Dispersions (ASD)

Utilizing hot-melt extrusion (HME) and spray-drying technologies to disperse hydrophobic compounds into hydrophilic polymer matrices, preventing recrystallization and significantly boosting kinetic solubility.

Lipid-Based Formulations (SEDDS/SMEDDS)

Engineering Self-Emulsifying and Self-Microemulsifying Drug Delivery Systems that spontaneously form sub-micron droplets in gastrointestinal fluids, bypassing dissolution-rate-limiting barriers.

Phyto-Micellar Nanocarriers

Tackling high-density botanical active polymers via natural phospholipid complexes (Phytosomes) and cyclodextrin supramolecular encapsulation, transforming insoluble botanical extracts into high-bioavailability actives.

Empirical Track Record

Proven Scale in CRO & CDMO Research

Decades of collaborative validation with premier pharmaceutical organizations, clinical university hospitals, and international formulators.

14+
Years of Natural Medicine CRO/CDMO Excellence
300+
Full-Time Phytochemists, Biologists & Engineers
100+
Pharma Groups & Hospital R&D Centers Served
400+
Single-Herb Extraction Standards Established
Global Market Dynamics

Addressing Global B2B Procurement Friction

Global pharmaceutical and nutraceutical brands often face disjointed supply chains, non-reproducible botanical chemistry, and severe dissolution failure during formulation scale-up.

De-risking Regulatory Audits

Global markets require full compliance with cGMP, ICH guidelines, and pharmacopeial monographs (USP, EP, ChP). We offer validated HPTLC, HPLC, GC, and LC-MS fingerprinting to eliminate adulteration and ensure consistent solubility specifications across global jurisdictions.

Single-Partner Accountability

Eliminate knowledge leaks and timeline extensions caused by handing formulation designs off between disparate CRO labs and manufacturing plants. Our integrated platform navigates the lifecycle from molecule screening directly to pilot and commercial batch release.

Direct IP & Proprietary Integrity

Operating under strict bilateral non-disclosure protocols, client assets, compound synthesis paths, excipient blends, and extraction parameters remain exclusively proprietary to ensure prolonged competitive market leadership.

Advanced Manufacturing

China Factory 4.0: Smart Botanical CDMO Resilience

Combining historical natural botanical wisdom with real-time Process Analytical Technology (PAT), automation, and closed-loop process engineering.

Automated Extraction & Refining

Continuous counter-current extraction loops paired with multi-stage membrane separations ensure optimal extraction yields while minimizing thermal degradation of fragile thermolabile molecules.

AI-Guided Particle Engineering

Dynamic monitoring of spray-drying parameters, inlet/outlet airflow, and nozzle shear rates controls amorphous particle size distributions (D50, D90) to maintain rapid dispersibility.

Upstream Agricultural Origin Sourcing

Direct supply-chain linkages across China's geo-authentic botanical growing basins (Daodi herbs) verify seasonal potency shifts, soil heavy metal baselines, and pesticide residual limits before lot dispatch.

End-to-End Traceability

MES-integrated processing infrastructure documents batch genealogy from raw botanical bale through downstream purification, ensuring non-repudiable audit trails for global authorities.

Multi-Sector Utility

Localized Application Scenarios & Finished Dosage Matrix

Bridging molecule optimization with commercial manufacturing formats tailored to market preferences across international territories.

High-Bioavailability Nutraceuticals

Instant-dissolve functional beverage powders, effervescent drink mixes, chewable delivery matrices, and liposomal softgels demanding rapid optical clarity and rapid gastrointestinal absorption.

Phytochemical Drug Candidates

Solid-state oral dosages (tablets, sustained-release coated capsules, oral emulsions) structured to pass Phase I through Phase IV human trials by meeting stringent dissolution and pharmacokinetic thresholds.

Dermatological Cosmeceuticals

Micro-encapsulated polyphenol extracts, water-dispersible essential fractions, and clear topical hydrogels requiring superior skin barrier penetration without precipitation or phase separation.

Client Collaborations

Trusted by Tier-One Pharma & Research Hospitals

A sample of leading domestic and international enterprises leveraging our CRO and CDMO solubility platforms.

China Beijing Tongrentang Group Co., Ltd. Beijing Tongrentang Group
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. China Resources Sanjiu
Sunflower Pharmaceutical Group Co., Ltd. Sunflower Pharmaceutical
Livzon Pharmaceutical Group Inc. Livzon Pharmaceutical
Yangtzi River Pharmaceutical Group Yangtzi River Pharma
Humanwell Healthcare (Group) Co., Ltd. Humanwell Healthcare
Apeloa Pharmaceutical Co., Ltd. Apeloa Pharmaceutical
Shuguang Hospital affiliated with Shanghai University of TCM Shuguang Hospital (Shanghai)
Technical Clarifications

Frequently Asked Questions for Global Procurement & Formulation Teams

In-depth responses resolving engineering parameters, quality verifications, and regulatory roadmaps.

What techniques are prioritized to increase the aqueous solubility of hydrophobic botanical extracts?
We evaluate active molecular structures using thermodynamic solubility profiling, selecting between Amorphous Solid Dispersions (ASD) with functional polymers (e.g., PVP/VA, HPMCAS), Self-Microemulsifying Drug Delivery Systems (SMEDDS), micronization, phospholipid phytosomal complexes, and cyclodextrin inclusion complexes depending on compound stability and target dosage requirements.
How does the team confirm batch-to-batch dissolution reproducibility?
Every production batch undergoes USP/EP/ChP-compliant in vitro dissolution apparatus testing (Apparatus 1 basket / Apparatus 2 paddle) combined with multi-channel automated HPLC/UV detection across multiple pH media (pH 1.2, 4.5, 6.8). We also track physical state purity via Powder X-Ray Diffraction (PXRD) and Differential Scanning Calorimetry (DSC) to confirm the complete absence of unwanted crystallization.
Can MedGence support Phase I–IV clinical studies and hospital registrations?
Yes. Our integrated CRO framework manages preclinical animal pharmacokinetics, acute/chronic toxicology (LD50), cellular in vitro assays, and complete human clinical trial management (Phase I to Phase IV). We have delivered 56 hospital preparation registrations and supported 22 innovative drug programs through comprehensive regulatory dossiers.
How do you protect client formulation IP and confidential process parameters?
We operate under legally enforceable bilateral Non-Disclosure Agreements (NDAs). All data, batch records, analytical methods, excipient proportions, and synthesis pathways are compartmentalized within secure digital data environments, ensuring client IP remains entirely uncompromised throughout laboratory screening and commercial production.
What finished dosage forms can be produced under your CDMO licenses?
Our facilities support active ingredients supplied as concentrated liquids, spray-dried powders, viscous pastes, and volatile essential fractions. For commercial finished products, we manufacture oral liquids, hard gelatin and vegetable capsules, softgels, direct-compression tablets, soluble powders, and functional effervescent granules.
Verified Pipeline

End-to-End Contract Capabilities

Procure validated research, preclinical validation, and manufacturing operations to accelerate your international launch timeline.

China Screening of the active ingredient(s) of plants Manufacturer
Active Botanical Ingredient High-Throughput Screening Service
Explore Capability
OEM Animal study Supplier, Suppliers
Preclinical Pharmacokinetic & Animal Toxicology Studies
Explore Capability
OEM In Vitro Test /Research Service Manufacturers
Cellular In Vitro Bioassay & Mechanism Screening
Explore Capability
ODM Clinic study Phase1-4 Manufacturer
Clinical Human Trials (Phase I – IV) Contract Organization
Explore Capability
Potency Evaluation Botanical Active Ingredients
Seasonal Harvest & Origin Potency Standardization
Explore Capability
Establishment of analysis methods of active ingredients
Analytical Method Development (HPLC, HPTLC, GC-MS)
Explore Capability
Process study for active ingredients
Phytochemical Industrial Scale-Up & Crystallization Studies
Explore Capability
CDMO contract manufacturing for finished products
Commercial cGMP Dosage Form CDMO Manufacturing
Explore Capability